Publications found:
264
Sort by:
Global Gemfibrozil API Market Growth 2026-2032
US$ 3,660.00
The global Gemfibrozil API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gemfibrozil API refers to the pure,...
March 2026
110 pages
Global Gemfibrozil Drugs Market Growth 2026-2032
US$ 3,660.00
The global Gemfibrozil Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gemfibrozil drugs are medications...
March 2026
118 pages
Global Icosapent Ethyl Drugs Market Growth 2026-2032
US$ 3,660.00
The global Icosapent Ethyl Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Icosapent ethyl drugs are a t...
March 2026
129 pages
Global Levosimendan Injection Market Growth 2026-2032
US$ 3,660.00
The global Levosimendan Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Levosimendan injection is a...
March 2026
80 pages
Global Omega-3 Fatty Acid Drugs Market Growth 2026-2032
US$ 3,660.00
The global Omega-3 Fatty Acid Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Omega-3 fatty acid drugs a...
March 2026
144 pages
Global PCSK9 Antagonists Market Growth 2026-2032
US$ 3,660.00
The global PCSK9 Antagonists market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. PCSK9 antagonists are a class of...
March 2026
122 pages
Global Triglyceride Lowering Drugs Market Growth 2026-2032
US$ 3,660.00
The global Triglyceride Lowering Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Triglyceride-lowering d...
March 2026
144 pages
India Statin Market Size, Share, Trends and Forecast by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region, 2026-2034
US$ 3,999.00
The India statin market size reached USD 534.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 676.6 Million by 2034, exhibiting a growth rate (CAGR) of 2.66% during 2026...
February 2026
141 pages
Global Zofenopril Calcium Market Growth 2026-2032
US$ 3,660.00
The global Zofenopril Calcium market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Zofenapril calcium, as a commonl...
January 2026
94 pages
Global Dabigatran Etexilate Drugs Market Growth 2026-2032
US$ 3,660.00
The global Dabigatran Etexilate Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Dabigatran etexilate is...
January 2026
145 pages
Global DTIs for Injection Market Growth 2026-2032
US$ 3,660.00
The global DTIs for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Direct Thrombin Inhibitors (DTIs...
January 2026
145 pages
Global Factor Xa Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Factor Xa Inhibitors market size is predicted to grow from US$ 24030 million in 2025 to US$ 35890 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032. Factor Xa inhi...
January 2026
146 pages
Global Oral Factor Xa Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Oral Factor Xa Inhibitors market size is predicted to grow from US$ 23480 million in 2025 to US$ 35570 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032. Oral Fact...
January 2026
128 pages
Global Rivaroxaban Drugs Market Growth 2026-2032
US$ 3,660.00
The global Rivaroxaban Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Rivaroxaban is an oral anticoagul...
January 2026
134 pages
Global Vericiguat Tablets Market Growth 2026-2032
US$ 3,660.00
The global Vericiguat Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Vericiguat tablets are a medicat...
January 2026
79 pages
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents), By Treatment (On-demand and Prophylaxis), By Therapy (Replacement Therapy, ITI therapy and Gene Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Haemophilia Treatment Market is projected to expand from USD 12.03 Billion in 2025 to USD 16.82 Billion by 2031, registering a CAGR of 5.75%. Treatment methodologies include replacement the...
January 2026
182 pages
Polycythemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary polycythemia, Secondary polycythemia, Pseudopolycythemia), By Treatment (Phlebotomy, Aspirin, Myelosuppressive Agents, Selective Serotonin Reuptake Inhibitor, Others), By Route of Administration (Oral, Intravenous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Polycythemia Market is projected to expand from USD 1.95 Billion in 2025 to USD 2.73 Billion by 2031, registering a compound annual growth rate of 5.77%. Polycythemia vera is a chronic myel...
January 2026
183 pages
Antithrombin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Usage (Therapeutics, Diagnostics, Research, Others), By Source (Human, Recombinant Goat Milk, Others), By Type (Anticoagulant, Antiplatelet, Thrombolytic Drugs), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antithrombin Market is projected to expand from USD 793.11 Million in 2025 to USD 1082.43 Million by 2031, registering a CAGR of 5.32%. As a vital liver-produced glycoprotein, antithrombin...
January 2026
186 pages
Atherosclerosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (Ankle-brachial Index, Doppler Ultrasound, Echocardiogram, Electrocardiogram, Blood Tests, Others), By Treatment (Medication, Surgery, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Atherosclerosis Drugs Market is projected to expand from USD 19.11 Billion in 2025 to USD 23.86 Billion by 2031, registering a CAGR of 3.77% throughout the forecast period. These pharmaceut...
January 2026
181 pages
Plasminogen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Intravenous Injection, Eye Drops), By Application (Ligneous Conjunctivitis, Diabetic Foot, Wound Healing, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Plasminogen Market is projected to expand from USD 2.79 Billion in 2025 to USD 3.83 Billion by 2031, reflecting a CAGR of 5.42%. Plasminogen is a glycoprotein zymogen that converts to plasm...
January 2026
180 pages
Venous Thromboembolism Prophylaxis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Lower Extremity, Upper Extremity), By End Use (Hospitals & Clinics, Ambulatory care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Venous Thromboembolism Prophylaxis Market is projected to expand from USD 6.89 Billion in 2025 to USD 9.57 Billion by 2031, progressing at a CAGR of 5.63%. This therapeutic sector encompass...
January 2026
185 pages
Heart Failure Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Heart Failure Therapeutics Market is projected to expand from USD 8.47 Billion in 2025 to USD 12.28 Billion by 2031, reflecting a compound annual growth rate of 6.39%. This sector encompass...
January 2026
180 pages
Ischemic Heart Disease (IHD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Class (Angina Pectoris, Myocardial Infarction), By Drug Class (Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, ACE Inhibitors, ARBs, Vasodilators, Antithrombotic Agents), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Ischemic Heart Disease (IHD) Drugs Market is projected to expand from a valuation of USD 6.23 Billion in 2025 to USD 7.98 Billion by 2031, progressing at a compound annual growth rate (CAGR...
January 2026
180 pages
Statin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Synthetic statin, Natural statin), By End-user (Hospitals & Clinics, Ambulatory Surgical Centers, others), By Region & Competition,, 2021-2031F
US$ 4,500.00
The Global Statin Market is projected to expand from USD 2.92 Billion in 2025 to USD 3.46 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 2.87%. Statins are pharmaceutical agents...
January 2026
182 pages
Polycythemia Vera Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Dasatinib, Idelalisib, Givinostat, M-009, Others), By End User (Hospitals& Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Polycythemia Vera Drug Market is projected to expand from USD 3.14 Billion in 2025 to USD 4.87 Billion by 2031, reflecting a compound annual growth rate of 7.59%. This market encompasses cy...
January 2026
182 pages
Clopidogrel Bisulphate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Formulation (Tablets, Capsules, Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Stroke, Peripheral Artery Disease, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clopidogrel Bisulphate Market is projected to expand from 7.98 Thousand Tonnes in 2025 to 11.59 Thousand Tonnes by 2031, reflecting a CAGR of 6.42%. Clopidogrel Bisulphate serves as a vital...
January 2026
185 pages
Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Factor Xa Inhibitors, Direct Thrombin Inhibitors), By Indication (Atrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke Prevention, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Direct Oral Anticoagulants (DOACs) Market is projected to expand from USD 33.36 Billion in 2025 to USD 51.92 Billion by 2031, reflecting a CAGR of 7.65%. These pharmaceuticals serve as spec...
January 2026
185 pages
Eltrombopag Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Tablets, Oral Suspension), By Application (Chronic Immune Thrombocytopenia, Hepatitis C, Severe Aplastic Anemia, Others), By End User (Hospitals and Clinics, Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Eltrombopag Drugs Market is projected to expand from USD 2.68 Billion in 2025 to USD 4.22 Billion by 2031, registering a compound annual growth rate of 7.86%. Eltrombopag functions as an or...
January 2026
180 pages
